# Feasibility of the LUM Imaging System for Detection of Prostate Cancer

> **NCT03441464** · PHASE1,PHASE2 · TERMINATED · sponsor: **Lumicell, Inc.** · enrollment: 9 (actual)

## Conditions studied

- Prostate Cancer
- Neoplasm, Residual

## Interventions

- **COMBINATION_PRODUCT:** LUM Imaging System

## Key facts

- **NCT ID:** NCT03441464
- **Lead sponsor:** Lumicell, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-03-20
- **Primary completion:** 2021-02-11
- **Final completion:** 2021-02-11
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Interim analysis indicated a change in study design to collect in vivo data
- **Last updated:** 2022-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03441464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03441464, "Feasibility of the LUM Imaging System for Detection of Prostate Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03441464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*